Final report

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

clinical study report; CSR; final report

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

HistoryThis section has been translated automatically.

A final report, also called Clinical Study Report, Final Report or CSR for short, is required for the regulatory compliant completion of a clinical study according to §13 paragraph 9 of the GCP regulation. The final report must make it possible to evaluate the study.

The final report contains in detail an introduction, the research question, a description of the methods used, the study design and all essential results of the clinical study. The results should be statistically evaluated and all primary and secondary questions should be answered so that conclusions can be drawn. With the help of the CSR, the regulatory authorities also evaluate the outcome of the study, which is particularly important for registration studies. Formal requirements apply to the Clinical Study Reports, regardless of whether the study is a commercial or non-commercial study.

General informationThis section has been translated automatically.

The requirements of the authorities are different, so that the BfArM demands a listing of all Adverse Events, Serious Adverse Events, Adverse Reactions, Serious Adverse Reactions and the SAR`s / SUSAR`s. While according to the BfArM, as an alternative to the final report, a publication with a supplementary list of the listed events is possible, according to the PEI a synopsis with all data must be submitted. The requirements of the competent ethics committees are not uniform, so that some ethics committees demand a final report or its synopsis; others, however, accept a publication.

For registration studies, a full CSR is required according to ICH Guideline E3.

The Clinical Study Report can be written either by the investigators, the sponsor or a Clinical Research Organisation (CRO).

Authors

Last updated on: 29.10.2020